Benzinga | Jun 16, 2021 11:50AM EDT

William Blair Downgrades Sage Therapeutics to Market Perform, Announces $62 Price Target

William Blair analyst Tim Lugo downgrades Sage Therapeutics (NASDAQ:SAGE) from Outperform to Market Perform and announces $62 price target.William Blair analyst Tim Lugo downgrades Sage Therapeutics (NASDAQ:SAGE) from Outperform to Market Perform and announces $62 price target.